Inactive Instrument

Insiders Enzon Pharmaceuticals, Inc. Other OTC

Equities

Enzon Pharmaceuticals, Inc. Announces Executive Changes	04/01/21	CI
Enzon Pharmaceuticals, Inc. Appoints Richard L. Feinstein as Secretary	04/01/21	CI
Enzon Pharmaceuticals, Inc. Announces Board Changes	07/08/20	CI
Jonathan Couchman Nominates Candidates to the Board of Enzon Pharmaceuticals	05/08/20	CI
Enzon Pharmaceuticals Inc. Announces Executive Changes	21/03/16	CI
Enzon Pharmaceuticals Inc. Announces Executive Changes	16/12/13	CI
Thomas F. Deuel Not to Stand for Re-Election as Director of Enzon Pharmaceuticals, Inc	22/10/13	CI
Enzon Pharmaceuticals Inc. Announces Board Changes	09/10/13	CI
Robert C. Salisbury Not to Stand for Re-Election as Director of Enzon Pharmaceuticals Inc	09/08/13	CI
Enzon Pharmaceuticals, Inc. Announces Executive Changes, Effective from August 9, 2013	25/07/13	CI
Enzon Pharmaceuticals Inc. and Aby Buchbinder Enters into a Severance Agreement for Termination Effective February 28, 2013	28/02/13	CI
Enzon Appoints Lazard To Sale Of Asset	17/12/12	CI
Enzon Pharmaceuticals Inc. Appoints George W. Hebard III as Director	28/02/12	CI

No results for this search